Stockscreener 앱 받기
0.4795
7.04%
-0.0363
시간 외 거래:
.48
0.0005
+0.10%
전일 마감가:
$0.5158
열려 있는:
$0.5055
하루 거래량:
191.62K
Relative Volume:
0.04
시가총액:
$2.11M
수익:
$75,000
순이익/손실:
$-40.08M
주가수익비율:
-0.00247
EPS:
-193.9456
순현금흐름:
$-16.26M
1주 성능:
-13.91%
1개월 성능:
-44.57%
6개월 성능:
-96.56%
1년 성능:
+0.00%
1일 변동 폭
$0.4702
$0.5156
1주일 범위
$0.4357
$0.5495
52주 변동 폭
$0.4101
$166.50
Profusa Inc Stock (PFSA) Company Profile
명칭
Profusa Inc
전화
212-494-9022
주소
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.4795 | 2.27M | 75,000 | -40.08M | -16.26M | -193.95 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc 주식(PFSA)의 최신 뉴스
Profusa granted transfer to Nasdaq Capital Market, faces July compliance deadline - MSN
Number of shareholders of PROFUSA, INC. – OTC:NVACW - TradingView
Profusa Granted Conditional Nasdaq Listing Extension and Transfer - TipRanks
Profusa, Inc. Granted Transfer to Nasdaq Capital Market Amid Compliance Efforts - Quiver Quantitative
Conditional Nasdaq listing relief for Profusa (NASDAQ: PFSA) - Stock Titan
Profusa Receives Favorable Nasdaq Listing Determination - Caledonian Record
Profusa keeps Nasdaq listing if it meets July 6 price and equity rules - Stock Titan
PFSA Technical Analysis & Stock Price Forecast - Intellectia AI
Profusa Secures New Convertible Note and Warrant Financing - TipRanks
Profusa (PFSA) insider-linked LLC converts $1.87M note into 5.34M shares - Stock Titan
Profusa (PFSA) CFO-linked LLC converts $1,869,796 note into 5.34M shares - Stock Titan
Profusa initiates strategic review, focuses on European approval By Investing.com - Investing.com Australia
Profusa initiates strategic review, focuses on European approval - Investing.com
Profusa Inc Profusa initiates board-led process to evaluate strategic alternatives and maximize shareholder value - marketscreener.com
Profusa Inc Profusa Initiates Board-Led Process To Evaluate Strategic Alternatives And Maximize Shareholder Value - TradingView
Profusa starts deal review after Lumee Oxygen completes two EU audits - Stock Titan
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value - marketscreener.com
[EFFECT] Profusa, Inc. SEC Filing - Stock Titan
EFFECT: Others - Moomoo
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
424B3: Prospectus - Moomoo
Profusa (PFSA) registers 179.3M resale shares, up to $100M ELOC funding - Stock Titan
Profusa (NASDAQ: PFSA) files S-1 for 179M-share resale and $100M equity line - Stock Titan
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Why did PFSA stock surge 80% pre-market today? - MSN
Profusa amends debt agreement and receives Nasdaq deficiency notice By Investing.com - Investing.com Australia
Profusa Faces Nasdaq Listing Risk Amid Financing Amendments - TipRanks
Profusa amends debt agreement and receives Nasdaq deficiency notice - Investing.com
Profusa Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Profusa (NASDAQ: PFSA) revises convertible note as Nasdaq listing risk rises - Stock Titan
Profusa (PFSA) resale S-1 details 179M shares and $100M equity line - Stock Titan
Trending Stocks Today | Profusa Soars 26.07% Pre-Market - Moomoo
Profusa Announces PanOmics Assay Know-How Acquisition Agreement - TipRanks
Profusa to Acquire PanOmics Assay Know-How From Bio Insights for $30 Million in Preferred Stock - TradingView
Profusa (NASDAQ: PFSA) to acquire PanOmics assay assets in $30M stock deal - Stock Titan
Profusa, Inc. Issues $1.1 Million Senior Secured Convertible Promissory Note and Warrant to Ascent Partners Fund LLC - Minichart
Profusa Raises $1.0 Million From Ascent via Secured Convertible Note; Issues $0.50 Warrant, Adds Lock-Up - TradingView
Profusa (NASDAQ: PFSA) adds secured convertible note and 3.33M-share warrant - Stock Titan
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa (PFSA) Stock Dividend Growth (Underperforming) 2026-04-20Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai
What's going on with Profusa stock Tuesday? - MSN
Profusa’s Next-Generation Biosensor Technology: Real-Time Biochemistry Monitoring for Chronic Disease Management and Telemedicine Applications - Minichart
Profusa, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Profusa (NASDAQ: PFSA) outlines Lumee biosensor pipeline, funding and 1-for-75 reverse split - Stock Titan
Profusa, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa Amends Financing and Pursues PanOmics Acquisition - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Profusa Inc (PFSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):